Evidence map›Paper›PMID 28848602›Full record

ArticleGastroenterology research and practice2017

Factors Predicting the Adherence to the Therapy of Italian IBD Patients.

Cristina Bucci, Fabiana Zingone, Stella Tammaro, Paola Iovino, Antonella Santonicola, Carolina Ciacci

Open access · goldAbstract read
In one paragraph

Article in Gastroenterology research and practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cristina BucciDepartment of Medicine and Surgery, Scuola Medica Salernitana, AOU San Giovanni di Dio and Ruggi d'Aragona, IBD Center at the University of Salerno, Salerno, Italy.ORCID 0000-0002-2179-217X
Fabiana ZingoneDepartment of Medicine and Surgery, Scuola Medica Salernitana, AOU San Giovanni di Dio and Ruggi d'Aragona, IBD Center at the University of Salerno, Salerno, Italy.ORCID 0000-0003-1133-1502
Stella TammaroDepartment of Medicine and Surgery, Scuola Medica Salernitana, AOU San Giovanni di Dio and Ruggi d'Aragona, IBD Center at the University of Salerno, Salerno, Italy.
Paola IovinoDepartment of Medicine and Surgery, Scuola Medica Salernitana, AOU San Giovanni di Dio and Ruggi d'Aragona, IBD Center at the University of Salerno, Salerno, Italy.ORCID 0000-0002-9568-0680
Antonella SantonicolaDepartment of Medicine and Surgery, Scuola Medica Salernitana, AOU San Giovanni di Dio and Ruggi d'Aragona, IBD Center at the University of Salerno, Salerno, Italy.
Carolina CiacciDepartment of Medicine and Surgery, Scuola Medica Salernitana, AOU San Giovanni di Dio and Ruggi d'Aragona, IBD Center at the University of Salerno, Salerno, Italy.ORCID 0000-0002-7426-1145
University of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInflammatory bowel diseases (IBD) are chronic gastrointestinal disorders influencing many aspects of the patient's life and accounting for substantial social costs. They require long-term therapies and regular contact with the clinic of reference. Our aim is to investigate therapy adherence and identify predictors of adherence.

methods151 patients were recruited in IBD clinic at the University of Salerno filled in the modified Morisky Medication Adherence Scale, a standardized questionnaire provided during the visit.

resultsOverall, 71.5% of the patients report to take all medications regularly. According to the scale, our population showed a 62.5% medium-high adherence to oral 5-ASA, a 72% medium-high adherence to immunomodulators, a 60% medium-high adherence to oral steroids, and 94.9% adherence to biologics. Younger patients tend to be less compliant to the therapy. The main reasons for the low adherence to therapy were the "hassle of sticking to the medication plan" and "their feeling better."

Identifiers

PMID28848602
PMCPMC5564107
OpenAlexW2743473841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.